VIRTIS: An imaging spectrometer for the Rosetta mission

…, S Erard, C Federico, G Filacchione, U Fink… - Space Science …, 2007 - Springer
The VIRTIS (Visual IR Thermal Imaging Spectrometer) experiment has been one of the most
successful experiments built in Europe for Planetary Exploration. VIRTIS, developed in …

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

…, K Herrmann, R Bredenkamp, H Höfler, U Fink… - The lancet …, 2007 - thelancet.com
Background In patients with locally advanced adenocarcinoma of the oesophagogastric
junction (AEG), early metabolic response defined by 18-fluorodeoxyglucose-PET ([ 18 F]FDG-…

[PDF][PDF] Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

H Wilke, P Preusser, U Fink, U Gunzer… - Journal of Clinical …, 1989 - Citeseer
(CR/PR) after EAP was 70%(23/33), including a 21%(7/33) rate of clinical CRs (CCRs). Two
patients had minor remission (MR)/no change and seven had progressive disease. There …

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

…, R Busch, JR Siewert, M Schwaiger, U Fink - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: Preoperative chemotherapy in patients with gastroesophageal cancer is
hampered by the lack of reliable predictors of tumor response. This study evaluates whether …

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

…, C Schulmacher, K Ott, U Fink… - … Journal of the …, 2003 - Wiley Online Library
BACKGROUND Neoadjuvant chemotherapy has shown some success in the treatment of
gastric carcinoma, but objective parameters for measuring its effects are lacking. The authors …

The organic-rich surface of comet 67P/Churyumov-Gerasimenko as seen by VIRTIS/Rosetta

…, M Combi, J Crovisier, T Encrenaz, C Federico, U Fink… - Science, 2015 - science.org
The VIRTIS (Visible, Infrared and Thermal Imaging Spectrometer) instrument on board the
Rosetta spacecraft has provided evidence of carbon-bearing compounds on the nucleus of …

Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the …

…, M Feith, BLDM Bruecher, H Bartels, U Fink - Annals of …, 2001 - journals.lww.com
Objective To analyze the changing pattern in tumor type and postoperative deaths at a
national referral center for esophageal cancer in the Western world and to assess prognostic …

Phase II study of gemcitabine in patients with advanced pancreatic cancer

J Carmichael, U Fink, RC Russell, MF Spittle… - British journal of …, 1996 - nature.com
The efficacy and safety of gemcitabine at a starting dose of 800 mg m2 administered once a
week for 3 weeks with 1 week's rest was investigated in chemonaive patients with advanced …

[PDF][PDF] Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

…, F Lordick, A Beer, M Schwaiger, U Fink… - Journal of Clinical …, 2004 - researchgate.net
… Wieder, Björn LDM Brücher, Frank Zimmermann, Karen Becker, Florian Lordick, Ambros
Beer, Markus Schwaiger, Ulrich Fink, Jörg Rüdiger Siewert, Hubert J. Stein, and Wolfgang A …

[PDF][PDF] Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction

…, R Busch, K Herrmann, H Wieder, U Fink… - Journal of clinical …, 2006 - researchgate.net
… Inter- and intraindividual comparisons of quantitative data were made by using a Mann-Whitney
U and a Wilcoxon signed rank test, respectively. Survival rates were estimated …